Skip to main content
. 2017 Oct 23;8(62):104960–104980. doi: 10.18632/oncotarget.21950

Table 3. Subgroup analysis of HR in overall survival (OS).

Analysis No. of studies No.of patients HR(95% CI) P value Model Heterogeneity
I2 (%) P
Subgroup1: patient origin
China 11 1062 0.357 (0.286–0.445) < 0.001 Fixed-effect 0.0% 0.713
Non-China 6 721 0.605 (0.410–0.895) 0.012 Random-effect 79% < 0.001
Subgroup 2 tumor types
Nervous system 3 1097 0.888 (0.399–1.974) 0.771 Random-effect 92% < 0.001
Head and neck squamous cell carcinoma 3 571 0.504 (0.177–1.440) 0.206 Random-effect 90% < 0.001
Respiratory system 6 1051 0.666 (0.557–0.797) < 0.001 Fixed-effect 25% 0.249
Gastrointestinal system 14 1798 0.674 (0.510–0.892) 0.006 Random-effect 78% < 0.001
Urinary and reproductive system 6 1995 0.720 (0.505–1.025) 0.068 Random-effect 78% < 0.001